Summary

GI Stool Testing Market – Scope of Report
TMR’s report on the global GI stool testing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global GI stool testing market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global GI stool testing market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the GI stool testing market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global GI stool testing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global GI stool testing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global GI stool testing market.

The report delves into the competitive landscape of the global GI stool testing market. Key players operating in the global GI stool testing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global GI stool testing market profiled in this report.

Key Questions Answered in Global GI stool testing Market Report
• What is the sales/revenue generated by GI stool testing across all regions during the forecast period?
• What are the opportunities in the global GI stool testing market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

GI Stool Testing Market – Research Objectives and Research Approach
The comprehensive report on the global GI stool testing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global GI stool testing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global GI stool testing market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global GI Stool Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global GI Stool Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global GI Stool Testing Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Consumables
6.3.2. Analyzers
6.4. Market Attractiveness, by Product Type
7. Global GI Stool Testing Market Analysis and Forecast, by Test Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Occult Blood Test
7.3.2. Ova and Parasites Test
7.3.3. Fecal Biomarkers Test
7.3.4. Others (Bacteria Test, etc.)
7.4. Market Attractiveness, by Test Type
8. Global GI Stool Testing Market Analysis and Forecast, by Indication
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Indication, 2020-2034
8.3.1. Infection
8.3.2. Inflammatory Bowel Disease
8.3.3. Gastroesophageal Reflux Disease
8.3.4. Cancer
8.3.5. Others (Poor Absorption Problems, etc.)
8.4. Market Attractiveness, by Indication
9. Global GI Stool Testing Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Diagnostic Centers & laboratories
9.3.3. Academic Institutes
9.3.4. Research Centers & Organizations
9.3.5. Others (Homecare Settings, etc.)
9.4. Market Attractiveness, by End-user
10. Global GI Stool Testing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America GI Stool Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Consumables
11.2.2. Analyzers
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Test Type, 2020-2034
11.4.1. Occult Blood Test
11.4.2. Ova and Parasites Test
11.4.3. Fecal Biomarkers Test
11.4.4. Others (Bacteria Test, etc.)
11.5. Market Attractiveness, by Test Type
11.6. Market Value Forecast, by Indication, 2020-2034
11.6.1. Infection
11.6.2. Inflammatory Bowel Disease
11.6.3. Gastroesophageal Reflux Disease
11.6.4. Cancer
11.6.5. Others (Poor Absorption Problems, etc.)
11.7. Market Attractiveness, by Indication
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Diagnostic Centers & laboratories
11.8.3. Academic Institutes
11.8.4. Research Centers & Organizations
11.8.5. Others (Homecare Settings, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Test Type
11.11.3. By Indication
11.11.4. By End-user
11.11.5. By Country
12. Europe GI Stool Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Consumables
12.2.2. Analyzers
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Occult Blood Test
12.4.2. Ova and Parasites Test
12.4.3. Fecal Biomarkers Test
12.4.4. Others (Bacteria Test, etc.)
12.5. Market Attractiveness, by Test Type
12.6. Market Value Forecast, by Indication, 2020-2034
12.6.1. Infection
12.6.2. Inflammatory Bowel Disease
12.6.3. Gastroesophageal Reflux Disease
12.6.4. Cancer
12.6.5. Others (Poor Absorption Problems, etc.)
12.7. Market Attractiveness, by Indication
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Diagnostic Centers & laboratories
12.8.3. Academic Institutes
12.8.4. Research Centers & Organizations
12.8.5. Others (Homecare Settings, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Test Type
12.11.3. By Indication
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific GI Stool Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Consumables
13.2.2. Analyzers
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Occult Blood Test
13.4.2. Ova and Parasites Test
13.4.3. Fecal Biomarkers Test
13.4.4. Others (Bacteria Test, etc.)
13.5. Market Attractiveness, by Test Type
13.6. Market Value Forecast, by Indication, 2020-2034
13.6.1. Infection
13.6.2. Inflammatory Bowel Disease
13.6.3. Gastroesophageal Reflux Disease
13.6.4. Cancer
13.6.5. Others (Poor Absorption Problems, etc.)
13.7. Market Attractiveness, by Indication
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Diagnostic Centers & laboratories
13.8.3. Academic Institutes
13.8.4. Research Centers & Organizations
13.8.5. Others (Homecare Settings, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Test Type
13.11.3. By Indication
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America GI Stool Testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Consumables
14.2.2. Analyzers
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Occult Blood Test
14.4.2. Ova and Parasites Test
14.4.3. Fecal Biomarkers Test
14.4.4. Others (Bacteria Test, etc.)
14.5. Market Attractiveness, by Test Type
14.6. Market Value Forecast, by Indication, 2020-2034
14.6.1. Infection
14.6.2. Inflammatory Bowel Disease
14.6.3. Gastroesophageal Reflux Disease
14.6.4. Cancer
14.6.5. Others (Poor Absorption Problems, etc.)
14.7. Market Attractiveness, by Indication
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Diagnostic Centers & laboratories
14.8.3. Academic Institutes
14.8.4. Research Centers & Organizations
14.8.5. Others (Homecare Settings, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Test Type
14.11.3. By Indication
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa GI Stool Testing Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Consumables
15.2.2. Analyzers
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Test Type, 2020-2034
15.4.1. Occult Blood Test
15.4.2. Ova and Parasites Test
15.4.3. Fecal Biomarkers Test
15.4.4. Others (Bacteria Test, etc.)
15.5. Market Attractiveness, by Test Type
15.6. Market Value Forecast, by Indication, 2020-2034
15.6.1. Infection
15.6.2. Inflammatory Bowel Disease
15.6.3. Gastroesophageal Reflux Disease
15.6.4. Cancer
15.6.5. Others (Poor Absorption Problems, etc.)
15.7. Market Attractiveness, by Indication
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Diagnostic Centers & laboratories
15.8.3. Academic Institutes
15.8.4. Research Centers & Organizations
15.8.5. Others (Homecare Settings, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Test Type
15.11.3. By Indication
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Abbott Laboratories
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Beckman Coulter, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Bio-Rad Laboratories
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. BioMérieux Inc.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Cardinal Health, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Cenogenics Corporation
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Epitope Diagnostics, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. ScheBo Biotech AG
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Quest Diagnostics
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Genova Diagnostics
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview